Locate your nearest certified outpatient SPRAVATO® treatment center

(0 miles away)

YType

1

Oliveira, Celia R MD

3301 NEW MEXICO AVE NW STE 345
WASHINGTON, DC, 20016

More information

3301 NEW MEXICO AVE NW STE 345, , WASHINGTON,, DC,, WASHINGTON, DC, 20016 , us (38.933700000000, -77.085135900000)

202-537-3833
(2 miles away)

YType

2

LAJE, GONZALO

5480 WISCONSIN AVE, SUITE 223
CHEVY CHASE, MD, 20815

More information

5480 WISCONSIN AVE, , SUITE 223, CHEVY CHASE,, MD,, CHEVY CHASE, MD, 20815 , us (38.963436400000, -77.087374900000)

301-576-6044
(3 miles away)

YType

3

OLIVER, PATRICK

1600 WILSON BLVD, SUITE 320
ARLINGTON, VA, 22209

More information

1600 WILSON BLVD, SUITE 320, , ARLINGTON,, VA,, ARLINGTON, VA, 22209 , us (38.894014100000, -77.077167200000)

703-340-1454

For more information and support for patients and their caregivers

Once you and your healthcare provider have decided that SPRAVATO® is right for you, Janssen CarePath will help you find the resources you may need to get started and stay on track. Janssen CarePath will give you information on your insurance coverage, potential out-of-pocket costs, and treatment support, and identify options that may help make your treatment more affordable.

Call a Janssen CarePath Care Coordinator at 877-CarePath (877-227-3728), Monday–Friday, 8:00 AM to 8:00 PM ET for more information, including help in finding a certified SPRAVATO® treatment center.

Visit JanssenCarePath.com/Spravato.

Coverage & Cost Support

Don’t see a center that works for you?

Sign up to get updates on new locations as they open up.

Sign Up

The information you provide will be used by Janssen Pharmaceuticals, Inc., our affiliates and our service providers to send you SPRAVATO® information updates, including about any certified SPRAVATO® treatment centers that open, and to fulfill any other requests you may make. You may ask to opt out of receiving these messages here. Our Privacy Policy further governs the use of the information you provide.

By providing the information and selecting the “Submit” button, you indicate that you have read, understand and agree to these terms.

All fields required

First Name: *

Last Name: *

Email: *

ZIP Code: *

I would like to receive communications from Spravato CRM *

Leave this field blank

A certified SPRAVATO® treatment center designated as "Now Treating Patients" is defined as having submitted evidence of completed patient monitoring as part of the SPRAVATO® REMS patient registry. Sites that are "Now Treating Patients" may not be accepting new patients. Please call to confirm.

Inclusion of certified SPRAVATO® treatment centers in this database does not represent an endorsement, referral or recommendation from Janssen Pharmaceuticals, Inc. Moreover, the certified SPRAVATO® treatment centers participating in this search feature do not necessarily endorse the use of any Janssen Pharmaceuticals, Inc., products.

This website offers the user the opportunity to locate and contact a certified SPRAVATO® treatment center. Inclusion of centers in this database is based on approval by authorized personnel for those certified SPRAVATO® treatment centers listed. This database is compiled for informational purposes only. No fees have been or will be received in exchange for participation in this database. In no event shall Janssen Pharmaceuticals, Inc., or its employees or agents be liable for any damages resulting from or related to this service. All providers and other users of this information agree that use of this service is at their own risk.

Janssen Pharmaceuticals, Inc., makes no representations as to whether any of the certified SPRAVATO® treatment centers participating in this search feature are covered by particular healthcare plans or insurers, if at all. Importantly, insurance verification is ultimately the responsibility of the provider. Users of this website are solely responsible for communications and interactions with any of the listed certified SPRAVATO® treatment centers or physician offices, and any information users send them is not governed by our Legal Notice and Privacy Policy. Users are responsible for compliance with state and federal laws regulating physician referrals, such as antikickback laws, the Stark Law or state professional practice restrictions.

What is the most important information I should know about SPRAVATO^®?

SPRAVATO^® can cause serious side effects, including:

Sedation and dissociation. SPRAVATO^® may cause sleepiness (sedation), fainting, dizziness, spinning sensation, anxiety, or feeling disconnected from yourself, your thoughts, feelings, space and time (dissociation).
- Tell your healthcare provider right away if you feel like you cannot stay awake or if you feel like you are going to pass out.
- Your healthcare provider must monitor you for serious side effects for at least 2 hours after taking SPRAVATO^®. Your healthcare provider will decide when you are ready to leave the healthcare setting.
Abuse and misuse. There is a risk for abuse and physical and psychological dependence with SPRAVATO^® treatment. Your healthcare provider should check you for signs of abuse and dependence before and during treatment with SPRAVATO^®.
- Tell your healthcare provider if you have ever abused or been dependent on alcohol, prescription medicines, or street drugs.
- Your healthcare provider can tell you more about the differences between physical and psychological dependence and drug addiction.
SPRAVATO^® Risk Evaluation and Mitigation Strategy (REMS). Because of the risks for sedation, dissociation, and abuse and misuse, SPRAVATO^® is only available through a restricted program called the SPRAVATO^® Risk Evaluation and Mitigation Strategy (REMS) Program. SPRAVATO^® can only be administered at healthcare settings certified in the SPRAVATO^® REMS Program. Patients treated in outpatient healthcare settings (e.g., medical offices and clinics) must be enrolled in the program.
Increased risk of suicidal thoughts and actions. Antidepressant medicines may increase suicidal thoughts and actions in some people 24 years of age and younger, especially within the first few months of treatment or when the dose is changed.
SPRAVATO^® is not for use in children
- Depression and other serious mental illnesses are the most important causes of suicidal thoughts and actions. Some people may have a higher risk of having suicidal thoughts or actions. These include people who have (or have a family history of) depression or a history of suicidal thoughts or actions.
How can I watch for and try to prevent suicidal thoughts and actions in myself or a family member?
- Pay close attention to any changes, especially sudden changes, in mood, behavior, thoughts, or feelings, or if you develop suicidal thoughts or actions.
- Tell your healthcare provider right away if you have any new or sudden changes in mood, behavior, thoughts, or feelings.
- Keep all follow-up visits with your healthcare provider as scheduled. Call your healthcare provider between visits as needed, especially if you have concerns about symptoms.
Tell your healthcare provider right away if you or your family member have any of the following symptoms, especially if they are new, worse, or worry you:
- suicide attempts
- thoughts about suicide or dying
- worsening depression
- other unusual changes in behavior or mood

Do not take SPRAVATO^® if you:

have blood vessel (aneurysmal vascular) disease (including in the brain, chest, abdominal aorta, arms and legs)
have an abnormal connection between your veins and arteries (arteriovenous malformation)
have a history of bleeding in the brain
are allergic to esketamine, ketamine, or any of the other ingredients in SPRAVATO^®.

If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO^®.

Before you take SPRAVATO^®, tell your healthcare provider about all of your medical conditions, including if you:

have heart or brain problems, including:
- high blood pressure (hypertension)
- slow or fast heartbeats that cause shortness of breath, chest pain, lightheadedness, or fainting
- history of heart attack
- history of stroke
- heart valve disease or heart failure
- history of brain injury or any condition where there is increased pressure in the brain
have liver problems
have ever had a condition called “psychosis” (see, feel, or hear things that are not there, or believe in things that are not true).
are pregnant or plan to become pregnant. SPRAVATO^® may harm your baby. You should not take SPRAVATO^® if you are pregnant.
- Tell your healthcare provider right away if you become pregnant during treatment with SPRAVATO^®.
- If you are able to become pregnant, talk to your healthcare provider about methods to prevent pregnancy during treatment with SPRAVATO^®.
- There is a pregnancy registry for women who are exposed to SPRAVATO^® during pregnancy. The purpose of the registry is to collect information about the health of women exposed to SPRAVATO^® and their baby. If you become pregnant during treatment with SPRAVATO^®, talk to your healthcare provider about registering with the National Pregnancy Registry for Antidepressants at 1-844-405-6185 or online at https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/antidepressants/.
are breastfeeding or plan to breastfeed. You should not breastfeed during treatment with SPRAVATO^®.

Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Taking SPRAVATO^® with certain medicine may cause side effects.

Especially tell your healthcare provider if you take central nervous system (CNS) depressants, psychostimulants, or monoamine oxidase inhibitors (MAOIs) medicines. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.

How will I take SPRAVATO^®?

You will take SPRAVATO^® nasal spray yourself, under the supervision of a healthcare provider in a healthcare setting. Your healthcare provider will show you how to use the SPRAVATO^® nasal spray device.
Your healthcare provider will tell you how much SPRAVATO^® you will take and when you will take it.
Follow your SPRAVATO^® treatment schedule exactly as your healthcare provider tells you to.
During and after each use of the SPRAVATO^® nasal spray device, you will be checked by a healthcare provider who will decide when you are ready to leave the healthcare setting.
You will need to plan for a caregiver or family member to drive you home after taking SPRAVATO^®.
If you miss a SPRAVATO^® treatment, your healthcare provider may change your dose and treatment schedule.
Some people taking SPRAVATO^® get nausea and vomiting. You should not eat for at least 2 hours before taking SPRAVATO^® and not drink liquids at least 30 minutes before taking SPRAVATO^®.
If you take a nasal corticosteroid or nasal decongestant medicine take these medicines at least 1 hour before taking SPRAVATO^®.

What should I avoid while taking SPRAVATO^®?

Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO^®. Do not take part in these activities until the next day following a restful sleep. See “What is the most important information I should know about SPRAVATO^®?”

What are the possible side effects of SPRAVATO^®?

SPRAVATO^® may cause serious side effects including:

See “What is the most important information I should know about SPRAVATO^®?”
Increased blood pressure. SPRAVATO^® can cause a temporary increase in your blood pressure that may last for about 4 hours after taking a dose. Your healthcare provider will check your blood pressure before taking SPRAVATO^® and for at least 2 hours after you take SPRAVATO^®. Tell your healthcare provider right away if you get chest pain, shortness of breath, sudden severe headache, change in vision, or seizures after taking SPRAVATO^®.
Problems with thinking clearly. Tell your healthcare provider if you have problems thinking or remembering.
Bladder problems. Tell your healthcare provider if you develop trouble urinating, such as a frequent or urgent need to urinate, pain when urinating, or urinating frequently at night.

The most common side effects of SPRAVATO^® when used along with an antidepressant taken by mouth include:

feeling disconnected from yourself, your thoughts, feelings and things around you
dizziness
nausea
feeling sleepy
spinning sensation
decreased feeling of sensitivity (numbness)
feeling anxious
lack of energy
increased blood pressure
vomiting
feeling drunk
feeling very happy or excited

If these common side effects occur, they usually happen right after taking SPRAVATO^® and go away the same day.

These are not all the possible side effects of SPRAVATO^®.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO^® and discuss any questions you may have with your healthcare provider.

cp-170363v1

Locate your nearest certified outpatient SPRAVATO® treatment center

All Filters

For more information and support for patients and their caregivers

Don’t see a center that works for you?

Sign up to get updates on new locations as they open up.

Sign Up

Sign Up